Activision Shares Tumble on Game Delays 
 

The videogame giant said it needs more time to finish making "Overwatch 2" and "Diablo IV" after leadership changes in its Blizzard Entertainment unit.


 
Mondelez Nudges Up Outlook Amid Inflation, Logistics Challenges 
 

The snack maker's profit, revenue rose in the latest quarter on what it said was solid volume growth and pricing that reflected inflationary pressures.


 
Zillow Quits Home-Flipping Business, Cites Inability to Forecast Prices 
 

The company's termination of tech-enabled "iBuying" comes after it said it was halting all new home purchases for the rest of the year.


 
Lyft Reports Higher Revenue as Ridership Returns 
 

The ride-hailing company had 18.9 million active riders in the latest quarter, edging closer to its pre-pandemic levels.


 
Goldman Sachs's 643 New Managing Directors Is Its Largest Class Ever 
 

The bank, under CEO David Solomon, has increased its overall head count and bolstered its asset-management and consumer arms.


 
Facebook to End Facial Recognition in Photos and Videos 
 

The social-media platform said it would delete data related to the faces of more than one billion people, scrapping a feature that raised concerns among privacy advocates and regulators.


 
Avis Stock Surges On Strong Quarterly Results 
 

The rental-car company's stock rose sharply in Tuesday, trading as high as $545 a share, after Avis delivered robust third-quarter profit.


 
Deere Workers Cast Ballots on New Contract Offer 
 

Striking employees represented by the United Auto Workers consider larger raises and bonuses, after last month rejecting an earlier deal between Deere and the union.


 
Justice Department Sues to Block Penguin Random House's Acquisition of Simon & Schuster 
 

The Justice Department filed a lawsuit seeking to block Penguin Random House from acquiring rival Simon & Schuster for nearly $2.18 billion, the latest in a series of aggressive antitrust cases brought under the Biden administration.


 
Pfizer Raises Covid-19 Vaccine Forecast as Sales More Than Double 
 

Pfizer increased its forecast for sales of the vaccine this year to about $36 billion, a roughly 7% boost from previous guidance.

(END) Dow Jones Newswires

11-02-21 1915ET